Abstract: The present technology relates to an information processing apparatus, an information processing method, and a program capable of checking a plurality of types of analysis results regarding one skin condition item intuitively and easily. The information processing apparatus according to one aspect of the present technology includes an acquisition unit configured to obtain information representing a plurality of types of analysis results on skin conditions obtained by analyzing an image of a skin at a same position, and a presentation unit configured to simultaneously display, on a same image, a plurality of types of visualized information obtained from visual representation of the plurality of types of analysis results. The present technology is applicable to a mobile terminal used together with a skin measurement instrument that photographs a skin image.

Abstract: The present technology relates to an information processing device and an information processing method capable of facilitating fixed-point observation on skin condition. The information processing device acquires an image that shows a predetermined feature point of a user who is a measurer of skin condition, and a measurement portion of skin condition, and analyzes the image, and then recognizes a position of the feature point. Furthermore, information indicating the measurement portion is displayed at a predetermined position on the image while setting, as a reference, the recognized position of the feature point. The present technology is applicable to information processing devices such as a tablet terminal, a smartphone, and a personal computer.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: The present technology relates to an information processing apparatus, an information processing method, and a program capable of checking a plurality of types of analysis results regarding one skin condition item intuitively and easily. The information processing apparatus according to one aspect of the present technology includes an acquisition unit configured to obtain information representing a plurality of types of analysis results on skin conditions obtained by analyzing an image of a skin at a same position, and a presentation unit configured to simultaneously display, on a same image, a plurality of types of visualized information obtained from visual representation of the plurality of types of analysis results. The present technology is applicable to a mobile terminal used together with a skin measurement instrument that photographs a skin image.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: The present technology relates to an information processing device, an information processing method, and a program capable of facilitating fixed-point observation on skin condition. The information processing device according to an aspect of the present technology acquires an image that shows a predetermined feature point of a user who is a measurer of skin condition, and a measurement portion of skin condition, and analyzes the image, and then recognizes a position of the feature point. Furthermore, information indicating the measurement portion is displayed at a predetermined position on the image while setting, as a reference, the recognized position of the feature point. The present technology is applicable to information processing devices such as a tablet terminal, a smartphone, and a personal computer.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: The present invention relates to the production of recombinant microorganisms, in particular of the genus Gluconobacter, for production of 2-keto-L-gulonic acid (2-KGA) and/or L-ascorbic acid (hereinafter also referred to as Vitamin C), wherein the microorganism has been modified to overexpress L-sorbose dehydrogenase (SDH). This overexpression has been achieved by introducing of one or more copies of a polynucleotide encoding SDH into the genome of the host microorganism resulting in enhanced yield, production, and/or efficiency of 2-KGA production and/or Vitamin C compared to a non-modified microorganism. Expression of said one or more extra-copies of sdh is dependent on the integration site. The invention also relates to genetically engineered microorganisms and their use for the production of 2-KGA and/or Vitamin C.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Abstract: Disclosed is a portable electronic game machine comprising: a chassis which can be in a basic configuration where each of a front plane, left plane, right plane, flat plane, bottom plane and rear plane is composed of a same number of blocks in vertical and horizontal directions and the chassis can change its configuration by rotating the block around three axis lines, wherein each block group provided aligned along each of the three axis lines is structured to be able to rotate around the axis line independently with respect to other block groups; part of the blocks is a game machine block; part of the remaining blocks is an information holding block to hold identification information; the game machine block includes an identification information detecting section; and the game section is structured to advance the game by reflecting a detected result by the identification information detecting section.

Abstract: The objective of the present invention is to provide a laminated phase retarder film that is superior in evenness, exhibits a biaxial optical property as a whole, and makes it possible to set the biaxial optical property over a wide range. This object is achieved by a laminated phase retarder film comprising a transparent resin film as a substrate and at least one coat layer having a refractive-index anisotropy laminated on at least one surface of the substrate, wherein a in-plane retardation value (R0) is not less than 20 nm, a retardation value (R?) in the film-thickness direction, which is calculated from a retardation value (R40) measured by inclining by 40 degrees around the slow axis of the film and the in-plane retardation value (R0), is greater than 40 nm.

Abstract: The present invention provides a polarizer having retarder, which has excellent uniformity and biaxial orientation as a whole, further capable of setting a wide range of optical characteristics of biaxial orientation, and provides a liquid crystal apparatus, to which the polarizer having retarder is applied. The polarizer having retarder comprises a polarizing film; and a phase retarder, which includes a substrate of a transparent film and at least one coat layer with birefringent anisotropy being on at least one surface of the substrate. The in-plane retardation value (R0) of the retarder is not less than 20 nm, and the retardation value along the thickness direction (R′) calculated based on the retardation value (R40) measured by inclining by 40° around the slow axis in the plane and the in-plane retardation value (R0) is more than 40 nm. The liquid crystal apparatus includes the polarizer having retarder combined with a liquid crystal cell.